JAK1 and hepatocellular carcinoma: To further evaluate whether bufalin inhibits HCC tumor metastasis in vitro and in vivo by targeting JAK1-ACAP4, we performed wound healing and transwell migration assays to assess the inhibitory effect of bufalin on IL6-induced hepatoma cell migration.